Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 729 of 6351
-
Can a diabetes drug tame PCOS symptoms?
Disease control CompletedThe Study aims to determine the proposed positive influence of Sitagliptin in manipulating hormonal , metabolic and inflammatory parameters in the treatment of Polycystic ovary syndrome and subsequent infertility
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental cocktail aims to tackle returning brain tumors
Disease control OngoingThis study consists of 2 portions. The phase 2 portion is an open-label, single-arm study to evaluate the safety and efficacy of NAI, PD-L1 t-haNK, and bevacizumab combination therapy in participants with recurrent or progressive GBM. The phase 2B portion is an open-label, random…
Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Parkinson's patients get brain transplants of their own cells
Disease control By invitation onlyThis research study is evaluating an investigational cell product called autologous induced pluripotent stem cell (iPSC)-derived dopamine neurons. This research study is a single-center Phase 1/2a clinical trial, which will test the safety of injecting the investigational cell pr…
Phase 1 • Sponsor: Penelope J. Hallett, Ph.D. • Aim: Disease control
Last updated Jun 26, 2026 16:38 UTC
-
New hope for rare protein disease: experimental drug targets relapsed amyloidosis
Disease control Recruiting nowThis study is researching an experimental drug called linvoseltamab ("study drug"). This study is focused on patients who have AL amyloidosis that has returned or have failed other therapies and need to be treated again. The study consists of 2 phases (Phase 1 and Phase 2): * …
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could brain zaps ease stroke pain? oxford trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if deep brain stimulation (DBS) works to treat severe pain following a stroke in adults. It will also learn about the safety of deep brain stimulation. The main questions it aims to answer are: * Does DBS lower the pain score in these …
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New triple therapy aims to shrink abdominal tumors in colorectal cancer
Disease control OngoingMain objective: 1\. To compare the objective response rate (ORR) of 18F-FAPI PET-guided abdominal region radiotherapy combined with second-line standard treatment versus cadonilimab and second-line standard treatment in the treatment of peritoneal metastasis of colorectal cancer…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can Ultrasound-Guided healing beat standard care for Crohn's?
Disease control Recruiting nowTransmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational studies suggest that TMH may be associated with better long-term outcomes. The study will evaluate TMH using noninvasive intestinal ul…
Phase 4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo tackles lung cancer brain tumors without surgery
Disease control Recruiting nowThis is a single arm phase 2 trial is to evaluate the efficacy of SRS plus adagrasib for the treatment of brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC). A total of 30 patients will be enrolled on this study.
Phase 2 • Sponsor: Ryan Gentzler, MD • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New chemo cocktail shows promise for pancreatic cancer patients before surgery
Disease control Recruiting nowThis phase II trial tests how well gemcitabine, cisplatin and nab-paclitaxel given before surgery (neoadjuvant) works in treating patients with pancreatic cancer that can be removed by surgery (resectable) or that is borderline resectable. The standard treatment for resectable an…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could vitamin d and iron tame OCD's impulse control?
Disease control By invitation onlyThis study is a randomized, open-labled, no-treatment-controlled clinical trial designed to investigate the effects of vitamin D and iron-immune homeostasis on inhibitory control and the underlying neural mechanisms in patients with obsessive-compulsive disorder (OCD). Participan…
Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new implant tame seizures when drugs fail?
Disease control CompletedThis is an open label, single arm, interventional, prospective first in human study, designed to evaluate the safety of the NAO.VNS SYSTEM.
Sponsor: Synergia Medical • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New smart drug targets HER2 lung cancer in Mid-Stage trial
Disease control Recruiting nowTQB2102 is an antibody-drug conjugate comprised of a humanised antibody against Human Epidermal Growth Factor Receptor 2 (HER2), a enzyme-cleavable linker, and a topoisomerase I inhibitor payload, which combine the ability of antibodies to specifically target tumour cells with th…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New CAR t therapy targets Hard-to-Treat ovarian cancers
Disease control Recruiting nowThis study is researching an experimental CAR T cell therapy called 27T51, referred to as study drug. The study drug is a MUC16 targeting immune cell therapy focused on adult female participants with recurrent or difficult to treat epithelial ovarian, primary peritoneal or fallop…
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New brain aneurysm device shows promise in major trial
Disease control OngoingTo establish the safety and effectiveness of the SEAL™ Saccular Endovascular Aneurysm Lattice system for the treatment of saccular intracranial aneurysms. The data from this study will be used to support a premarket approval (PMA) submission.
Phase 3 • Sponsor: Galaxy Therapeutics INC • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New pill could take the edge off social anxiety on the spot
Symptom relief CompletedThe purpose of the study is to evaluate the effect of a single, acute dose of BNC210 compared to placebo on reducing the severity of anxiety provoked by a behavioral assessment task and measured using the Subjective Units of Distress Scale (SUDS) in adult patients with social anx…
Phase 3 • Sponsor: Bionomics Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Exercise in the hospital: a new way to help heart failure patients help themselves?
Disease control CompletedThe objective of the study is to evaluate the effectiveness of a self-care program that integrates physical exercise with components of aerobic and muscular strength training in improving functional capacity and muscular strength in people hospitalized for decompensated heart fai…
Sponsor: Centro Hospitalar Universitário de Santo António • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New pill aims to tame rare blood vessel disease
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of iptacopan compared to standard of care (SOC) to induce and maintain remission in study participants with active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), when used in combination w…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a blue dye help reverse septic shock?
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of methylene blue among adult patients with septic shock.
Phase 3 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New CLL trial aims to reduce Life-Threatening side effect of cancer drugs
Disease control Recruiting nowChronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess the safety of venetoclax in combination with obinutuzumab or acalabrutinib in the treatment of CLL. Adverse events and change in disease activity will be…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy takes on tough lung cancer
Disease control OngoingThis is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer (ES-SCLC) (Cohort 1) or small-cell lung cancer (SCLC) which has progressed on first- or second-line treatment (Cohort 2 and Cohort 3). This study …
Phase 2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC